March 13, 2026

Invitation to Swedencare AB (publ) pre Q1 2026 update

Swedencare (publ) invites you to a brief presentation and Q&A session ahead of the company’s upcoming interim report for the first quarter of 2026. The presentation will take place on March 20^th at 10:30 CET and will be available via live webinar.

Swedencare invites investors and analysts to a short presentation and Q&A session where CEO Håkan Lagerberg and CFO Jenny Graflind will participate. The purpose of the session is to provide a brief update and an opportunity to ask questions before Swedencare enters its quiet period ahead of the publication of the Q1 report on April 23^rd, 2026.

The presentation will be held in English, and participants joining the live webinar will have the opportunity to ask questions following the session. No prior registration is required.

The webinar can be accessed via this link: https://us06web.zoom.us/j/89475678468
The presentation will be published in connection with the live webinar, and a recording will be made available on the website later the same day at www.swedencare.com.

About Swedencare

Swedencare is listed on the NASDAQ First North Growth Market and also trades on the OTCQX® Best Market. We develop, produce, and sell premium products in the global and rapidly growing pet healthcare market, focusing on cats, dogs, and horses. Our extensive product portfolio includes strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, Rileys®, and ProDen PlaqueOff®, the original solution for good oral health.

With headquarters in Malmö, our products are sold in approximately 70 countries through online channels, pet stores, veterinarians, and FDMC. Our extensive distribution network consists of subsidiaries in nine countries, along with an international network of retailers. Swedencare has experienced strong growth for several years while maintaining high profitability.

Attached file

Invitation to Swedencare AB (publ) pre Q1 2026 update

Stay up to date